Literature DB >> 21769602

Age-related changes in the mRNA levels of CYP1A1, CYP2B1/2 and CYP3A1 isoforms in rat small intestine.

Artur Pałasz1, Anna Wiaderkiewicz, Ryszard Wiaderkiewicz, Piotr Czekaj, Beata Czajkowska, Tomasz Lebda-Wyborny, Aneta Piwowarczyk, Aleksandra Bryzek.   

Abstract

It has been established beyond doubt that, as well as the liver, the small intestine is an important site of first-pass metabolism of numerous drugs, food components and toxic xenobiotics. However, there is not much information available about age-dependent changes of intestinal biotransformation pathways. In the present paper, we evaluated the relationships between intestinal cytochrome P450 complex activity and the age of animals. The study was carried out on male Sprague-Dawley rats (n = 5) from 5 age series: 0.5-, 2-, 4-, 20-, and 28 months old. Animals at every age series were divided into 4 groups: control and three groups of rats treated with the CYP450 specific inducers: phenobarbital, β-naphtoflavone and dexamethasone, respectively. RNA was isolated from intestinal mucosa, and then standard RT-PCR was used for the analysis of CYP1A1, CYP2B1/2 and CYP3A1 mRNA expression. Additionally, the activities of NADPH-cytochrome P450 and NADH-cytochrome b(5) reductases in the microsomal fraction were biochemically estimated. The constitutive intestinal CYP1A1 mRNA expression changes during maturation and aging. Inducibility of CYP1A1 gene was evident in intestinal mucosa at 2-, 4- and 20-month-old rats. A similar pattern of changes was observed for CYP2B1/2 isoforms. CYP3A1 mRNA expression was not detected in small intestine of 2-week-old rats. In matured rats, constitutive intestinal CYP3A1 expression was low, although after induction, significant increases in CYP3A1 mRNA amount were noted in aged individuals. Intestinal activity of both analyzed reductases was lowest in immature rats and highest in 28-month-old animals. In conclusion, the activity of cytochrome P450 complex in rat small intestine was not decreased by the aging processes, so the high rate of oxidative metabolic reactions in intestinal mucosa can be maintained till the advanced life stage.

Entities:  

Year:  2011        PMID: 21769602      PMCID: PMC3316744          DOI: 10.1007/s12263-011-0240-z

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  52 in total

1.  Grapefruit juice--drug interactions: importance for pharmacotherapy.

Authors:  Magdalena Cuciureanu; L Vlase; Dana Muntean; Irina Varlan; Rodica Cuciureanu
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2010 Jul-Sep

2.  Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes.

Authors:  C Emoto; H Yamazaki; S Yamasaki; N Shimada; M Nakajima; T Yokoi
Journal:  Xenobiotica       Date:  2000-10       Impact factor: 1.908

3.  Characterization of human small intestinal cytochromes P-450.

Authors:  Q Y Zhang; D Dunbar; A Ostrowska; S Zeisloft; J Yang; L S Kaminsky
Journal:  Drug Metab Dispos       Date:  1999-07       Impact factor: 3.922

4.  Modulation of cytochrome P450 1A1 by food-derived heterocyclic aromatic amines.

Authors:  Jörg Hümmerich; Christoph Zohm; Wolfgang Pfau
Journal:  Toxicology       Date:  2004-07-01       Impact factor: 4.221

5.  Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats.

Authors:  Doreen Mitschke; Andreas Reichel; Gert Fricker; Ursula Moenning
Journal:  Drug Metab Dispos       Date:  2008-03-10       Impact factor: 3.922

6.  Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress?

Authors:  Valérie Wauthier; Roger K Verbeeck; Pedro Buc Calderon
Journal:  Arch Toxicol       Date:  2003-11-05       Impact factor: 5.153

7.  Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney.

Authors:  Jill S Warrington; David J Greenblatt; Lisa L von Moltke
Journal:  J Pharmacol Exp Ther       Date:  2004-01-23       Impact factor: 4.030

8.  In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat.

Authors:  Tsutomu Kotegawa; Bart E Laurijssens; Lisa L Von Moltke; Monette M Cotreau; Michael D Perloff; Karthik Venkatakrishnan; Jill S Warrington; Brian W Granda; Jerold S Harmatz; David J Greenblatt
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

9.  Age-dependent change of metabolic capacity and genotoxic injury in rat intestine.

Authors:  H R Patel; A Hewer; J D Hayes; D H Phillips; F C Campbell
Journal:  Chem Biol Interact       Date:  1998-05-01       Impact factor: 5.192

10.  Effects of enteral nutrition and ethanol on cytochrome P450 distribution in small intestine of male rats.

Authors:  R Hakkak; M J Ronis; T M Badger
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  4 in total

1.  Intestinal cytochromes P450 regulating the intestinal microbiota and its probiotic profile.

Authors:  Eugenia Elefterios Venizelos Bezirtzoglou
Journal:  Microb Ecol Health Dis       Date:  2012-09-07

Review 2.  An update on the role of intestinal cytochrome P450 enzymes in drug disposition.

Authors:  Fang Xie; Xinxin Ding; Qing-Yu Zhang
Journal:  Acta Pharm Sin B       Date:  2016-08-04       Impact factor: 11.413

3.  Does age matter? The impact of rodent age on study outcomes.

Authors:  Samuel J Jackson; Nick Andrews; Doug Ball; Ilaria Bellantuono; James Gray; Lamia Hachoumi; Alan Holmes; Judy Latcham; Anja Petrie; Paul Potter; Andrew Rice; Alison Ritchie; Michelle Stewart; Carol Strepka; Mark Yeoman; Kathryn Chapman
Journal:  Lab Anim       Date:  2016-07-10       Impact factor: 2.471

4.  Comparative transcriptomic profiling of hydrogen peroxide signaling networks in zebrafish and human keratinocytes: Implications toward conservation, migration and wound healing.

Authors:  Thomas S Lisse; Benjamin L King; Sandra Rieger
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.